RE: Trading23 Feb 2021 12:07
Great RNS, this bit stands out for sure.
"Dr. Sepe Sehati, Chief Scientific and Regulatory Affairs Lead at Love Hemp, says "It's been a huge pleasure to spend the past few months leading a dedicated team to compile a robust evidence-based dossier for submission to the FSA. To my knowledge, Love Hemp's application is also in the unique position of having provided comprehensive pre-clinical results, based on our own proprietary study protocols, investigating the effects of Love Hemp's finished product formulations on the pharmacokinetics of CBD. To have been able to do this at pre-validation stage is a great achievement."